JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
EDITORIAL Free access
Minerva Medica 2023 December;114(6):767-9
DOI: 10.23736/S0026-4806.23.08936-X
Copyright © 2023 EDIZIONI MINERVA MEDICA
language: English
COVID-19 and endocrine disorders: a potential new trigger
Xavier CAPÓ 1, Giuseppe ANNUNZIATA 2, Manuel JIMÉNEZ-GARCIA 3, 4 ✉, Giovanna MUSCOGIURI 5, 6, Luigi BARREA 7
1 Translational Research in Aging and Longevity (TRIAL) Group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain; 2 Department of Experimental Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy; 3 Group of Neurophysiology, Department of Biology, Faculty of Science, University of the Balearic Islands, Palma, Spain; 4 Group of Neurophysiology, Behavioral Studies and Biomarkers, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain; 5 Unit of Endocrinology, Diabetology and Andrology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 6 Cattedra Unesco “Educazione alla Salute e allo Sviluppo Sostenibile”, University of Naples Federico II, Naples, Italy; 7 Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, Naples, Italy